Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report)’s share price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $9.23 and traded as high as $9.39. Bavarian Nordic A/S shares last traded at $9.29, with a volume of 4,552 shares.
Bavarian Nordic A/S Trading Down 0.1 %
The stock has a market capitalization of $2.20 billion, a PE ratio of 13.46 and a beta of 1.65. The stock has a 50 day moving average price of $9.23 and a 200-day moving average price of $10.04.
Bavarian Nordic A/S Company Profile
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.
Read More
- Five stocks we like better than Bavarian Nordic A/S
- Insider Buying Explained: What Investors Need to Know
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- How to Read Stock Charts for Beginners
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Bavarian Nordic A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic A/S and related companies with MarketBeat.com's FREE daily email newsletter.
